Heat Biologics, Inc. (HTBX) has seen some recent activity in the stock market and its common shares were last quoted at $2.1300 yesterday. Investors are starting to take notice of HTBX as the common shares traded as high as $2.1800 and as low as $2.0200 in the prior market trading session.
Heat Biologics, Inc. (HTBX) average trading volume is 29.57M. However, in the prior market trading session Heat Biologics, Inc. (HTBX) traded 11,599,689 shares. The 1st support level on HTBX is $2.09 and the 1st upside resistance level on HTBX is $4.05. HTBX 50 day moving average is $1.5294 and HTBX 200day moving average is $0.8025.
Heat Biologics, Inc. (HTBX) most current performance has been specified by the recent movement in HTBX common shares. HTBX has performed 152.10% over the past 30 days, HTBX has performed 284.68% over the past 3 months and HTBX has shown 248.61% over the past 12 months. Heat Biologics, Inc. (HTBX) has a 1 year range of $0.2000 to $4.3000. Heat Biologics, Inc. (HTBX) is trading 992.31% from its 1 year low and -50.47% from its 1 year high. Heat Biologics, Inc. (HTBX) is showing a 2.86% short float showing the sum short in the float.
HTBX has 82.70M shares outstanding and 75.53M shares in the float. Heat Biologics, Inc. (HTBX) presently has a market cap of $301.54M and income of -20.60M. The EPS next quarter for HTBX is -0.10 and projected EPS next year is 0.00%. The market cap of Heat Biologics, Inc. (HTBX) at $301.54M signifies how many Investors own shares of HTBX and is calculated off the last price ($2.1300) of HTBX and the sum of shares outstanding (82.70M) with Heat Biologics, Inc. (HTBX).
Heat Biologics, Inc. (HTBX) has total cash (mrq) of 26.44M, total cash per share (mrq) of 0.31, total debt of HTBX rests at 2.03M and total debt/equity (mrq) is 7.65. . Heat Biologics, Inc. (HTBX) operating cash flow (ttm) is -14.44M, HTBX leveraged free cash flow (ttm) is -6.86M.
HTBX is trading 6.13% above (bullish) its SMA20, 62.84% above (bullish) its SMA50 and 210.39% above (bullish) its SMA200.